SIETES :: 93061 citas

Resultados de la búsqueda por ANALGÉSICOS REFINAR BÚSQUEDA

1.

Gaibar L. El consumo de psicofármacos entre la población asalariada se ha duplicado desde el inicio de la pandemia . El Salto 2020:20 de mayo. [Ref.ID 103621]

2.

Nici L, Mammen MJ, Charbek E, Alexander PE, Au DH, Boyd C, Criner GJ, Donaldson GC, Dreher M, Fan VS, Gershon AS, et al.. Pharmacologic management of chronic obstructive pulmonary disease. An official American Thoracic Society clinical practice guideline . Am J Respir Crit Care Med 2020;201:1 de mayo. [Ref.ID 103620]

3.

Torjesen I. Covid-19: NICE advises against using NSAIDs for fever in patients with suspected cases. BMJ 2020;369:6 de abril. [Ref.ID 103585]

4.

Little P. Non-steroidal anti-inflammatory drugs and covid-19. BMJ 2020;368:27 de marzo. [Ref.ID 103583]

5.

Barnett ML. Opioid prescribing in the midst of crisis — Myths and realities. N Engl J Med 2020;382:19 de marzo. [Ref.ID 103579]

6.

Anónimo. FDA advises patients on use of non-steroidal anti-inflammatory drugs (NSAIDs) for COVID-19. U.S. Food and Drug Administration 2020:19 de marzo. [Ref.ID 103572]

7.

Day M. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists. BMJ 2020;368:17 de marzo. [Ref.ID 103563]

8.

Just KS, Dormann H, Böhme M, Schurig M, Schneider KL, Steffens M, Dunow S, Plank-Kiegele B, Ettrich K, Seufferlein T, Gräff I, Igel S, Schricker S, Jaeger SU, Schwab MStingl J. Personalising drug safety—results from the multi-centre prospective observational study on Adverse Drug Reactions in Emergency Departments (ADRED). Eur J Clin Pharmacol 2020;76:marzo. [Ref.ID 103531]

9.

Saragiotto BT, Abdel Shaheed C, Maher CG. Paracetamol for pain in adults. BMJ 2020;367:17 de enero. [Ref.ID 103510]

10.

Mahase E. Gabapentinoids: has reclassification really solved the problem?. BMJ 2020;368:13 de enero. [Ref.ID 103509]

11.

Anónimo. Neurontin, Gralise, Horizant (gabapentin) and Lyrica, Lyrica CR (pregabalin): Drug safety communication - Serious breathing problems. U.S. Food and Drug Administration 2019:19 de diciembre. [Ref.ID 103239]

12.

13.

Ji Y, Azuine RE, Zhang Y, Hou W, Hong X, Wang G, Riley A, Pearson C, Zuckerman B, Wang X. Association of cord plasma biomarkers of in utero acetaminophen exposure with risk of attention-deficit/hyperactivity disorder and autism spectrum disorder in childhood. JAMA Psychiatry 2019:30 de octubre. [Ref.ID 103208]

14.

Smith BH, Fletcher EH, Calvin LA. Opioid prescribing is rising in many countries. BMJ 2019;367:17 de octubre. [Ref.ID 103203]

15.

Taylor P. J&J hit by $8bn judgment for man claiming breast growth due to Risperdal. PMLiVE 2019:9 de octubre. [Ref.ID 103192]

16.

Pfrepper C, Deters S, Metze M, Siegemund R, Gockel I, Petros S. Metamizole inhibits arachidonic acid-induced platelet aggregation after surgery and impairs the effect of aspirin in hospitalized patients. Eur J Clin Pharmacol 2019;75:777-84. [Ref.ID 103175]

17.

Vélez AM. La dueña del monopolio del opio en España oculta los sueldos de su cúpula tras la salida del multimillonario Abelló . eldiario.es 2019:11 de septiembre. [Ref.ID 103173]

18.

Beddoes ZM. Johnson & Johnson, Purdue and other opioid-peddlers face a reckoning. The Economist 2019:1. [Ref.ID 103165]

19.

Finnerub NB. Nonnarcotic methods of pain management. N Engl J Med 2019;380:20 de junio. [Ref.ID 103139]

20.

Schiek S, Hildebrandt K, Zube O, Bertsche T. Fall-risk-increasing adverse reactions - is there value in easily accessible drug information? A case-control study. Eur J Clin Pharmacol 2019;75:junio. [Ref.ID 103137]